Acupuncture for Postoperative Pain After Abdominal Surgery for Gynecological Diseases
Combined Electroacupuncture and Auricular Acupuncture for Postoperative Pain After Abdominal Surgery for Gynecological Diseases: A Randomized Sham-controlled Trial
1 other identifier
interventional
72
1 country
2
Brief Summary
Objectives: To examine the efficacy and safety of electroacupuncture (EA) combined with auricular acupuncture (AA) in reducing post-operative pain in patients following abdominal surgery for gynecological diseases. Hypothesis: Acupuncture is effective and safe to reduce postoperative pain during the first 5 days following surgery as compared to a sham control. Design and strategy: This is a randomized, placebo-controlled, subject- and assessor-blind trial. Seventy-two subjects will be recruited and randomized (in 1:1 ratio) to receive either acupuncture treatment or sham control. Subjects in both groups will undergo standard operation procedure and receive post-operative analgesics based on usual care. Study instrument: A 10-point pain Numerical Rating Scale (NRS) will be employed as a primary outcome assessment. Intervention: Subjects in the treatment group will receive EA combined with AA within two hours before operation, post-operation upon arrival to the ward and once a day for the subsequent 5 days. Subjects in the control group will receive non-invasive sham procedure in the same schedule. Main outcome measures: Primary outcome: NRS pain scores will be measured upon recovery, hourly at 6 hours after surgery, then 4-hourly until day 2, 6-hourly until day 3 and once daily until discharge. Secondary outcome: Morphine consumption, post-operative syndromes, quality of recovery questionnaire, SF-6D, EQ-5D-5L and adverse events will be documented and compared between groups. Data analysis: Pain intensity during the first 5 days will be calculated by Area Under the Curve (AUC) of NRS pain scores. AUC between the two groups will be compared by Student's T-test. Expected outcome: AUC of the acupuncture group is expected to be significantly lower than sham acupuncture group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable postoperative-pain
Started Oct 2016
Longer than P75 for not_applicable postoperative-pain
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2016
CompletedFirst Posted
Study publicly available on registry
August 1, 2016
CompletedStudy Start
First participant enrolled
October 12, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2018
CompletedSeptember 17, 2019
September 1, 2019
2.1 years
July 19, 2016
September 13, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Area under the curve of Pain intensity by numerical rating scale (NRS) from baseline to day 5
5 days
Secondary Outcomes (9)
Pain intensity by numerical rating scale (NRS) at rest
Through study completion, an average of 7 days
Pain intensity by numerical rating scale (NRS) while coughing
Through study completion, an average of 7 days
Cumulative morphine consumption
Through study completion, an average of 7 days
Dose of rescues analgesic (IM morphine) use
Through study completion, an average of 7 days
Frequency of rescues analgesic (IM morphine) use
Through study completion, an average of 7 days
- +4 more secondary outcomes
Other Outcomes (5)
Number of patients withdraw
Through study completion, an average of 7 days
Reasons of withdrawal
Through study completion, an average of 7 days
Number of subjects with adverse events
Through study completion, an average of 7 days
- +2 more other outcomes
Study Arms (2)
Electroacupuncture (EA) and Auricular Acupuncture (AA)
EXPERIMENTALSubjects in the treatment group will receive EA combined with AA two hours before operation, immediately post-operation and once a day for the subsequent 5 days.
Sham acupuncture
SHAM COMPARATORSubjects in the control group will receive non-invasive sham procedure in the same schedule as the treatment group.
Interventions
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists (ASA) physical status I to III
- Eligible for laparotomy with midline incision for gynaecological neoplasm including ovarian mass, uterine mass and cervical lesions
- Age 18 years or above
- Ability to understand the nature of the study and willing to give informed consent
- Capable of providing responses during outcome measurement
You may not qualify if:
- Having chronic pain and using any medication in addition to the anaesthetic and analgesia prescribed prior to surgery that would be expected to affect the dosage of postoperative analgesia
- History of or current alcohol or drug abuse
- Impaired renal function, defined as preoperative serum creatinine level over 120µmol/L
- Impaired hepatic function, defined as preoperative serum albumin level below 30g/L
- Impaired or retarded mental state and not able to sign the consent
- Not self-ambulatory before operation
- Difficulties in using patient-controlled analgesia
- BMI \> 35kg/m2
- Infection observed at the acupoint sites
- History of acupuncture experience in the previous 12 months
- History or clinical evidence of valvular heart defects, heart failure, atrial fibrillation or bleeding disorders or are fitted with cardiac pacemaker or taking anticoagulant drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Kwong Wah Hospital
Hong Kong, Hong Kong
Queen Mary Hospital
Hong Kong, Hong Kong
Related Publications (1)
Lam WL, Yeung WF, Wong MK, Cheung CW, Chan KKL, Ngan HYS, Wong CKH, Chen HY, Lao L. Combined electroacupuncture and auricular acupuncture for postoperative pain after abdominal surgery for gynecological diseases: study protocol for a randomized controlled trial. Trials. 2018 Jan 4;19(1):8. doi: 10.1186/s13063-017-2359-8.
PMID: 29301556DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lixing LAO
The University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2016
First Posted
August 1, 2016
Study Start
October 12, 2016
Primary Completion
November 1, 2018
Study Completion
November 1, 2018
Last Updated
September 17, 2019
Record last verified: 2019-09